Wakefield, MA · Founded 2011 · Privately Held (backing)
Developer of catheter-based neurolytic delivery systems designed for therapeutic intervention in hypertension. Ablative Solutions is based in Wakefield, MA and was founded in 2011. Its last reported valuation was $140 million in Jun 2022. It has raised $215 million across 4 recorded rounds; the latest was a $10.4 million early-stage round in Nov 2025.
Last reported valuation
$140.0M
Oct 2026
Priced at
—
Total raised
$214.6M
Last round
Early Stage VC
Nov 2025
Team — not yet on record
No current team members for Ablative Solutions are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ablative Solutions with a free account
·The complete investor list: 11 names
·Watch Ablative Solutions: the Monday email on marks, rounds and moves
